PUBMED FOR HANDHELDS

Journal Abstract Search


484 related items for PubMed ID: 27544322

  • 41. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [Abstract] [Full Text] [Related]

  • 42. Hypertension in children with congenital adrenal hyperplasia.
    Maccabee-Ryaboy N, Thomas W, Kyllo J, Lteif A, Petryk A, Gonzalez-Bolanos MT, Hindmarsh PC, Sarafoglou K.
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):528-34. PubMed ID: 27105393
    [Abstract] [Full Text] [Related]

  • 43. Diagnosis and management of classical congenital adrenal hyperplasia.
    Marumudi E, Khadgawat R, Surana V, Shabir I, Joseph A, Ammini AC.
    Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
    [Abstract] [Full Text] [Related]

  • 44. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
    Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
    Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
    [Abstract] [Full Text] [Related]

  • 45. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
    J Pediatr; 2002 Aug 06; 141(2):247-52. PubMed ID: 12183722
    [Abstract] [Full Text] [Related]

  • 46. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW.
    Ann Clin Biochem; 2014 Jul 06; 51(Pt 4):424-40. PubMed ID: 24711560
    [Abstract] [Full Text] [Related]

  • 47. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 48. [Diagnosis of the adrenogenital syndrome caused by 11beta-hydroxylase deficiency using gas chromatographic-mass spectrometric analysis of the urinary steroid profile].
    Wudy SA, Homoki J, Wachter UA, Teller WM.
    Dtsch Med Wochenschr; 1997 Jan 03; 122(1-2):3-10; discussion 11. PubMed ID: 9064231
    [Abstract] [Full Text] [Related]

  • 49. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W, Schmidt H, Schwarz HP.
    Horm Res Paediatr; 2011 Jan 03; 75(1):32-7. PubMed ID: 20714115
    [Abstract] [Full Text] [Related]

  • 50. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
    Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
    J Pediatr Endocrinol Metab; 2012 Jan 03; 25(9-10):977-81. PubMed ID: 23426829
    [Abstract] [Full Text] [Related]

  • 51. Reduced activity of 11β-hydroxylase accounts for elevated 17α-hydroxyprogesterone in preterms.
    Kamrath C, Hartmann MF, Boettcher C, Wudy SA.
    J Pediatr; 2014 Aug 03; 165(2):280-4. PubMed ID: 24862381
    [Abstract] [Full Text] [Related]

  • 52. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW, Ma HM, Su Z, Du ML, Li YH, Chen HS, Chen QL.
    Zhonghua Er Ke Za Zhi; 2012 Apr 03; 50(4):301-7. PubMed ID: 22801236
    [Abstract] [Full Text] [Related]

  • 53. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
    Bacila I, Freeman N, Daniel E, Sandrk M, Bryce J, Ali SR, Yavas Abali Z, Atapattu N, Bachega TA, Balsamo A, Birkebæk N, Blankenstein O, Bonfig W, Cools M, Costa EC, Darendeliler F, Einaudi S, Elsedfy HH, Finken M, Gevers E, Claahsen-van der Grinten HL, Guran T, Güven A, Hannema SE, Higham CE, Iotova V, van der Kamp HJ, Korbonits M, Krone RE, Lichiardopol C, Luczay A, Mendonca BB, Milenkovic T, Miranda MC, Mohnike K, Neumann U, Ortolano R, Poyrazoglu S, Thankamony A, Tomlinson JW, Vieites A, de Vries L, Ahmed SF, Ross RJ, Krone NP.
    Eur J Endocrinol; 2021 Apr 03; 184(4):553-563. PubMed ID: 33460392
    [Abstract] [Full Text] [Related]

  • 54. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.
    Reisch N, Idkowiak J, Hughes BA, Ivison HE, Abdul-Rahman OA, Hendon LG, Olney AH, Nielsen S, Harrison R, Blair EM, Dhir V, Krone N, Shackleton CH, Arlt W.
    J Clin Endocrinol Metab; 2013 Mar 03; 98(3):E528-36. PubMed ID: 23365120
    [Abstract] [Full Text] [Related]

  • 55. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H, Sempé M, Morel Y, Forest MG, de Peretti E, David M.
    Arch Fr Pediatr; 1985 Mar 03; 42(7):511-6. PubMed ID: 2935112
    [Abstract] [Full Text] [Related]

  • 56. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ, Yong AB, Warne GL, Montalto J.
    J Paediatr Child Health; 1995 Feb 03; 31(1):47-50. PubMed ID: 7748691
    [Abstract] [Full Text] [Related]

  • 57. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
    Horm Res; 2008 Feb 03; 70(1):42-50. PubMed ID: 18493149
    [Abstract] [Full Text] [Related]

  • 58. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
    J Clin Endocrinol Metab; 2002 Jul 03; 87(7):3197-200. PubMed ID: 12107224
    [Abstract] [Full Text] [Related]

  • 59. The balance of cortisol-cortisone interconversion is shifted towards cortisol in neonates with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kamrath C, Hartmann MF, Wudy SA.
    J Steroid Biochem Mol Biol; 2014 Sep 03; 143():386-91. PubMed ID: 24861266
    [Abstract] [Full Text] [Related]

  • 60. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
    Völkl TM, Rauh M, Schöfl C, Dörr HG.
    Growth Horm IGF Res; 2011 Aug 03; 21(4):191-8. PubMed ID: 21636299
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.